RE:RE:re: presentation
yeah Sah, context is easilly lost sometimes isnt it !?
This traded $1.43 less than 60 days ago.
If you had asked me then how I would feel about a $3.15 share price, in combination with a NR that suggests a high likelihood of 4050 Human efficacy in T2D and Metabolic syndrome... and an extremely conservative RBC analyst increasing price target to $4.50 ... and definitive word from the company that more related news is imminent... I think i would have said AWESOME ! somehow it doesnt feel awesome today !... but the fact is... it probably IS